1. Home
  2. NNNN vs TSI Comparison

NNNN vs TSI Comparison

Compare NNNN & TSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNNN
  • TSI
  • Stock Information
  • Founded
  • NNNN 2021
  • TSI 1987
  • Country
  • NNNN Germany
  • TSI United States
  • Employees
  • NNNN N/A
  • TSI N/A
  • Industry
  • NNNN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • TSI Investment Managers
  • Sector
  • NNNN Health Care
  • TSI Finance
  • Exchange
  • NNNN Nasdaq
  • TSI Nasdaq
  • Market Cap
  • NNNN 267.7M
  • TSI 231.3M
  • IPO Year
  • NNNN 2025
  • TSI N/A
  • Fundamental
  • Price
  • NNNN $6.43
  • TSI $4.91
  • Analyst Decision
  • NNNN
  • TSI
  • Analyst Count
  • NNNN 0
  • TSI 0
  • Target Price
  • NNNN N/A
  • TSI N/A
  • AVG Volume (30 Days)
  • NNNN 28.8K
  • TSI 106.8K
  • Earning Date
  • NNNN 01-01-0001
  • TSI 01-01-0001
  • Dividend Yield
  • NNNN N/A
  • TSI 7.46%
  • EPS Growth
  • NNNN N/A
  • TSI N/A
  • EPS
  • NNNN 0.06
  • TSI N/A
  • Revenue
  • NNNN $8,185,146.00
  • TSI N/A
  • Revenue This Year
  • NNNN N/A
  • TSI N/A
  • Revenue Next Year
  • NNNN N/A
  • TSI N/A
  • P/E Ratio
  • NNNN $118.17
  • TSI N/A
  • Revenue Growth
  • NNNN 21.95
  • TSI N/A
  • 52 Week Low
  • NNNN $5.18
  • TSI $4.48
  • 52 Week High
  • NNNN $7.82
  • TSI $4.87
  • Technical
  • Relative Strength Index (RSI)
  • NNNN N/A
  • TSI 57.57
  • Support Level
  • NNNN N/A
  • TSI $4.85
  • Resistance Level
  • NNNN N/A
  • TSI $4.93
  • Average True Range (ATR)
  • NNNN 0.00
  • TSI 0.04
  • MACD
  • NNNN 0.00
  • TSI 0.01
  • Stochastic Oscillator
  • NNNN 0.00
  • TSI 84.62

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

About TSI TCW Strategic Income Fund Inc.

Tcw Strategic Income Fund Inc operates as a closed-end management investment company. Its investment objective is to seek a total return comprised of current income and capital appreciation by investing in a wide range of securities. The company invests in a range of industries, such as airlines, banks, beverages, biotechnology, chemicals, computers, diversified financial services, entertainment and others.

Share on Social Networks: